Bifidobacterium spp.
- Generic Name
- Bifidobacterium spp.
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- IO1WP3918D
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression
Not Applicable
Completed
- Conditions
- Adolescent Depression
- Interventions
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Zhen-Hong Hu
- Target Recruit Count
- 100
- Registration Number
- NCT06325605
- Locations
- 🇨🇳
Tangshan Workers' Hospital, Tangshan, Hebei, China
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics
Phase 4
Not yet recruiting
- Conditions
- Cancer Therapy-related Cardiovascular Toxicity
- Interventions
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05730777
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- University of Campania "Luigi Vanvitelli"
- Target Recruit Count
- 40
- Registration Number
- NCT02807064
- Locations
- 🇮🇹
Second University, Naples, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath